Fidelity Select Biotechnology Portfolio (FBIOX)

Fund Assets	4.28B
Expense Ratio	0.66%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	0.23
Dividend Yield	1.19%
Dividend Growth	186.25%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Dec 13, 2024

Previous Close	19.30
YTD Return	2.12%
1-Year Return	0.42%
5-Year Return	40.56%
52-Week Low	17.43
52-Week High	22.47
Beta (5Y)	0.65
Holdings	187
Inception Date	Dec 16, 1985

About FBIOX

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Average
• Risk Rating: High
• Stock Exchange: NASDAQ
• Ticker Symbol: FBIOX
• Index: S&P 500 TR

Performance

FBIOX had a total return of 0.42% in the past year. Since the fund's inception, the average annual return has been 12.03%, including dividends.

Top 10 Holdings

50.64% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	13.66%
Amgen Inc.	AMGN	7.26%
Krystal Biotech, Inc.	KRYS	6.92%
Vertex Pharmaceuticals Incorporated	VRTX	4.49%
Regeneron Pharmaceuticals, Inc.	REGN	3.98%
Gilead Sciences, Inc.	GILD	3.60%
Alnylam Pharmaceuticals, Inc.	ALNY	3.60%
UCB SA	UCB	2.50%
argenx SE	ARGX	2.49%
Ascendis Pharma A/S	ASND	2.14%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 13, 2024	$0.166	Dec 16, 2024
Apr 12, 2024	$0.063	Apr 15, 2024
Dec 27, 2023	$0.002	Dec 28, 2023
Dec 1, 2023	$0.078	Dec 4, 2023
Dec 17, 2021	$1.098	Dec 20, 2021
Apr 9, 2021	$1.703	Apr 12, 2021